{"id":"W7127005839","doi":"","title":"Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study","year":2010,"lang":"en","type":"article","venue":"Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Refractory (planetary science); Myeloid leukaemia; Salvage therapy; Mitoxantrone; Gemtuzumab ozogamicin; Phases of clinical research; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009951745,0.0009523291,0.003785096,0.000381831,0.0003521442,0.0006657877,0.0007375126,0.0007424088,0.001301908],"category_scores_gemma":[0.0006584065,0.0003175242,0.001377573,0.0004452367,0.0007424916,0.0006205184,0.0002969398,0.001935664,0.0003665841],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009150129,"about_ca_system_score_gemma":0.001007603,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001393099,"about_ca_topic_score_gemma":0.002583421,"domain_scores_codex":[0.9996581,0.0001528226,0.00001957647,0.0000522327,0.000038727,0.00007854415],"domain_scores_gemma":[0.9995409,0.0001022431,0.00008863551,0.00005771463,0.0000161693,0.0001943401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5638174,0.04909692,0.0351088,0.001414543,0.004021179,0.001412866,0.0006585921,0.004393301,0.03480723,0.0003409901,0.00388104,0.3010471],"study_design_scores_gemma":[0.3997736,0.5043756,0.07658736,0.0001734924,0.002653524,0.001797257,0.0002370575,0.001841651,0.006438867,0.0003095337,0.005763738,0.00004834369],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950526,0.003579833,0.0002083347,0.0001355898,0.00004149048,0.0002658189,0.0002798046,0.00002342614,0.0004129801],"genre_scores_gemma":[0.9922196,0.004061852,0.0007285122,0.0003531346,0.0001292173,0.0004724121,0.001453023,0.00001858231,0.0005637621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003785096,"threshold_uncertainty_score":0.006638885,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01415848423778248,"score_gpt":0.2615461679053376,"score_spread":0.2473876836675551,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}